Invention Grant
US08853385B2 Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
有权
组合疗法包括SGLT抑制剂和DPP4抑制剂
- Patent Title: Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
- Patent Title (中): 组合疗法包括SGLT抑制剂和DPP4抑制剂
-
Application No.: US12863429Application Date: 2009-01-16
-
Publication No.: US08853385B2Publication Date: 2014-10-07
- Inventor: Kiichiro Ueta , Kenji Arakawa , Yasuaki Matsushita
- Applicant: Kiichiro Ueta , Kenji Arakawa , Yasuaki Matsushita
- Applicant Address: JP Osaka-shi
- Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee Address: JP Osaka-shi
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/JP2009/051023 WO 20090116
- International Announcement: WO2009/091082 WO 20090723
- Main IPC: C07H7/04
- IPC: C07H7/04
Abstract:
The present invention relates to combination therapy comprising a DPP4 inhibitor and an SGLT inhibitor. The combination of the present invention leads to increase plasma GLP-1 level and the combination is useful for prevention or treatment of conditions such as diabetes and diseases related to diabetes.
Public/Granted literature
- US20110059912A1 COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS Public/Granted day:2011-03-10
Information query
